08045800513
Send Inquiry
Send InquiryMetformin,Glimperide & Atorvastatin Combination
MOQ : 15-30 Boxes
Metformin,Glimperide & Atorvastatin Combination Specification
- Drug Type
- Specific Drug
- Ingredients
- Glimepride 2 mg + Pioglitazone 30 mg (SR)
- Physical Form
- Tablets
- Function
- Other
- Recommended For
- Treatment of Type 2 Diabetes Mellitus associated with dyslipidemia
Metformin,Glimperide & Atorvastatin Combination Trade Information
- Minimum Order Quantity
- 15-30 Boxes
- Payment Terms
- Western Union, Paypal, Cash in Advance (CID), Cheque, Cash Advance (CA)
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- Blister Pack, 5*2*10
- Main Domestic Market
- All India
- Certifications
- WHO-GMP
About Metformin,Glimperide & Atorvastatin Combination
Metformin, Glimperide & Atorvastatin Combination is a specialized medication formulated for the treatment of Type 2 Diabetes Mellitus associated with dyslipidemia. The tablets integrate three powerful active ingredients: Metformin, Glimpride, and Atorvastatin. Available in two strengths, Exeed-AG-1 (500 mg Metformin + 1 mg Glimpride + 10 mg Atorvastatin) and Exeed-AG-2 (500 mg Metformin + 2 mg Glimpride + 10 mg Atorvastatin), this combination targets better glucose control while addressing abnormal cholesterol levels. Designed for adults and aged individuals, the tablets come in convenient physical form and are classified as specific drugs. This medication is recommended for achieving dual benefits: enhanced glycemic management and improved lipid profile in patients affected by diabetes complications. Tailored for export and supply, its quality ensures compliance with therapeutic standards.
FAQs of Metformin,Glimperide & Atorvastatin Combination:
Q: What is the purpose of this combination medication?
A: It is used to treat Type 2 Diabetes Mellitus associated with dyslipidemia by improving blood sugar control and managing cholesterol levels.Q: Who is this medication suitable for?
A: It is suitable for adults and aged individuals requiring treatment for diabetes and lipid abnormalities.Q: What are the active ingredients in this product?
A: The tablets contain Metformin, Glimpride, and Atorvastatin in varying strengths as mentioned.Q: How is this medication classified?
A: It is classified as a specific drug for managing Type 2 Diabetes Mellitus with dyslipidemia.Q: In what forms is this medication available?
A: It is available in tablet form with two different combinations for varying dosage needs.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
More Products in Diabetic Tablets Category
Voglibose 0.2 mg & 0.3 mg
Minimum Order Quantity : 1530 Boxes
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Physical Form : Tablets
Function : Other
Drug Type : Specific Drug
Recommended For : To enhance Glycaemic Control
Tenegliptin with Metformin Combination
Minimum Order Quantity : 1530 Boxes
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Physical Form : Tablets
Function : Other
Drug Type : Specific Drug
Recommended For : Type 2 Diabetes Mellitus
Glimperide, Metformin & Pioglitazone Combination (Extended Release)
Minimum Order Quantity : 1530 Boxes
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Physical Form : Tablets
Function : Other
Drug Type : Specific Drug
Recommended For : Management of Type 2 diabetes (NIDDM)
Voglibose 0.3 mg & Metformin 500 mg (SR)
Minimum Order Quantity : 1530 Boxes
Ingredients : Glimepride 2 mg + Pioglitazone 30 mg (SR)
Physical Form : Tablets
Function : Other
Drug Type : Specific Drug
Recommended For : Type II Diabetes
Contact Details
- Call us-9877184734, 6283732271, Plot No. 364, Industrial Area, Phase-1,Chandigarh - 160002, India
- Phone : 08045800513
GST : 04AAHCS5485R1ZJ
- Mr Sanjeev Kumar Sethi (Managing Director)
- Mobile : 08045800513
- cmd@solitairegroup.in
- Mobile :+919815777744
SOLITAIRE PHARMACIA PVT. LTD.
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
